Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2
- PMID: 12445035
- PMCID: PMC1874453
- DOI: 10.1046/j.1365-2125.2002.01686.x
Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2
Abstract
Aims: To evaluate the effect of the CYP1A2*1C and CYP1A2*1F polymorphisms on the inducibility of CYP1A2 by omeprazole in healthy subjects.
Methods: Mutations of CYP2C19 and CYP1A2 were identified by PCR-RFLP. Omeprazole, 120 mg day-1, was given to 12 extensive metabolizers (EM) with respect to CYP2C19 (six CYP1A2*1F/CYP1A2*1F and six CYP1A2*1C/CYP1A2*1F of CYP1A2) for 7 days. CYP1A2 activity was determined on three occasions, namely on day 1, day 9 and day 16 using the caffeine plasma index (the ratio of the concentrations of paraxanthine to caffeine), 6 h after oral administration of 200 mg caffeine.
Results: There was a significant difference (P = 0.002) between the caffeine ratios for CYP1A2*1F/CYP1A2*1F and CYP1A2*1C/CYP1A2*1F genotypes on day 9, but not on day 1 or day 16 (P > 0.05). The changes in the ratios from day 9 to day 1 (48% +/- 20%vs 19% +/- 20%) and from day 9 to day 16 (50% +/- 31%vs 15% +/- 22%) were significantly different (P < 0.05) between the CYP1A2*1F/CYP1A2*1F and CYP1A2*1C/CYP1A2*1F genotypes.
Conclusion: The CYP1A2*1C and CYP1A2*1F genetic polymorphisms influenced the induction of CYP1A2 activity in vivo by omeprazole.
Figures
Similar articles
-
Quercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2*1C (-2964G>A) and *1F (734C>A) gene polymorphisms.Biomed Res Int. 2014;2014:405071. doi: 10.1155/2014/405071. Epub 2014 Jun 15. Biomed Res Int. 2014. PMID: 25025048 Free PMC article.
-
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.Eur J Clin Pharmacol. 2006 Jan;62(1):23-8. doi: 10.1007/s00228-005-0057-z. Epub 2005 Dec 30. Eur J Clin Pharmacol. 2006. PMID: 16385402
-
Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis.Clin Transl Sci. 2019 Jan;12(1):39-46. doi: 10.1111/cts.12598. Epub 2018 Nov 26. Clin Transl Sci. 2019. PMID: 30387917 Free PMC article.
-
Human cytochrome P4501A2.IARC Sci Publ. 1999;(148):173-95. IARC Sci Publ. 1999. PMID: 10493258 Review.
-
Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.AAPS J. 2009 Sep;11(3):481-94. doi: 10.1208/s12248-009-9127-y. Epub 2009 Jul 10. AAPS J. 2009. PMID: 19590965 Free PMC article. Review.
Cited by
-
Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management.Ther Clin Risk Manag. 2013;9:259-71. doi: 10.2147/TCRM.S43151. Epub 2013 May 27. Ther Clin Risk Manag. 2013. PMID: 23745048 Free PMC article.
-
Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report.Life (Basel). 2021 Jul 9;11(7):673. doi: 10.3390/life11070673. Life (Basel). 2021. PMID: 34357045 Free PMC article.
-
Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.Mol Genet Genomics. 2015 Apr;290(2):709-25. doi: 10.1007/s00438-014-0956-8. Epub 2014 Dec 4. Mol Genet Genomics. 2015. PMID: 25472037
-
Rational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions.World J Gastroenterol. 2007 Nov 14;13(42):5618-28. doi: 10.3748/wjg.v13.i42.5618. World J Gastroenterol. 2007. PMID: 17948937 Free PMC article. Review.
-
PharmGKB summary: very important pharmacogene information for CYP1A2.Pharmacogenet Genomics. 2012 Jan;22(1):73-7. doi: 10.1097/FPC.0b013e32834c6efd. Pharmacogenet Genomics. 2012. PMID: 21989077 Free PMC article. No abstract available.
References
-
- Xu ZH, Zhou HH. Cytochrome P450 1A2 in drug metabolism. J Clin Pharmacol. 1996;12:115–121.
-
- Han XM, Zhou HH. Polymorphism of CYP450 and cancer susceptibility. Acta Pharmacol Sin. 2000;21:673–679. - PubMed
-
- Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo) 1999;125:803–808. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources